TrangAston :verified: · @CastlTrAstonDrs
1181 followers · 1967 posts · Server med-mastodon.com

@Nature The crowd targets its next cancer mutations. Clinic-ready inhibitors, degraders and molecular glues are pushing cancer frontiers by targeting KRAS variants including KRAS-G12D.
📌 nature.com/articles/d41573-023
📌 nature.com/articles/d41573-019
📌 cancer.gov/research/key-initia

#oncologresearch #cancerbiology #KRAS

Last updated 1 year ago

@STAkrog · @STAkrog
8 followers · 413 posts · Server mstdn.social

V Postojni pripravili prvo borzo turističnih ponudnikov krog.sta.si/3138464

#KRAS #razvoj #borza #turizem

Last updated 1 year ago

ashish(@tp53) · @acgt01
42 followers · 1410 posts · Server genomic.social

RT @norbertkraut1@twitter.com

The KRAS crowd targets its next cancer mutations nature.com/articles/d41573-023
Insightful piece by @AsherMullard@twitter.com on drugging beyond G12C mutants in @NatRevDrugDisc@twitter.com inhibitors, molecular glues, degraders and more to come.

🐦🔗: twitter.com/norbertkraut1/stat

#KRAS #krasg12d #pankras

Last updated 2 years ago

Benedikt Mandl · @mandl
115 followers · 206 posts · Server mstdn.science

RT @norbertkraut1
The KRAS crowd targets its next cancer mutations nature.com/articles/d41573-023
Insightful piece by @AsherMullard on drugging beyond G12C mutants in @NatRevDrugDisc inhibitors, molecular glues, degraders and more to come.

#KRAS #krasg12d #pankras

Last updated 2 years ago

Filip Janku · @CancerDoc
54 followers · 32 posts · Server med-mastodon.com

I am excited to see this paper coming up. Signals of activity noted with mono therapy and combination with cetuximab

nejm.org/doi/full/10.1056/NEJM

#KRAS #g12c #colorectalcancer #TargetedTherapy #adagrasib

Last updated 2 years ago

Filip Janku · @CancerDoc
54 followers · 31 posts · Server med-mastodon.com

I am excited to see this paper coming up. Signals of activity noted with mono therapy and combination with cetuximab

nejm.org/doi/full/10.1056/NEJM

#KRAS #g12c #colorectalcancer #TargetedTherapy #adagrasib

Last updated 2 years ago

Rio Sugimura · @rio_sugimura
145 followers · 445 posts · Server med-mastodon.com

RT @StephenVLiu@twitter.com

Preclinical report of G12D inhibitor MRTX1133 @CD_AACR@twitter.com. Efficacy noted in pancreatic models and interesting effect on the tumor microenvironment with this agent. Important target in NSCLC as well and this mutation often occurs in non-smokers.

aacrjournals.org/cancerdiscove

🐦🔗: twitter.com/StephenVLiu/status

#KRAS

Last updated 2 years ago

Data presented by @tajiknia shows MRTX1133 suppression of pERK at nM doses & synergies with 5-FU in CRC & pancreatic cancer cells with G12D, G12V, & G13D. More studies needed before excluding non-G12D mutations from trials @BrownUCancer @BrownMedicine

#aacrjca22 #KRAS #eldeirylab

Last updated 2 years ago

Josh Goldstein · @JoshGoldstein523
38 followers · 20 posts · Server med-mastodon.com

Project Livin’ Label: Sotorasib
Nicole Drezner of the FDA Oncology Center of Excellence leads a discussion of the development of sotorasib, an inhibitor that targets the KRAS G12C mutant, for adult patients with locally advanced or metastatic non-small cell . CME credit available: bit.ly/3iMJfKE

#lungcancer #FDA #oncology #CME #cancerresearch #fdaapproval #KRAS

Last updated 2 years ago

Gregory Riely · @RielyMD
2 followers · 2 posts · Server med-mastodon.com
sally church · @maverickny
1 followers · 5 posts · Server mstdn.science

Hello everyone, I'm a scientist who now writes about cool science in the oncology arena. Currently interested in and other emerging areas of interest.

#TPD #KRAS #MYC

Last updated 2 years ago